Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study (Q37066194)
Jump to navigation
Jump to search
scientific article published on 17 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study |
scientific article published on 17 May 2013 |
Statements
1 reference
Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study (English)
1 reference
Richard M A Follows
1 reference
Neil G Snowise
1 reference
Shu-Yen Ho
1 reference
Claire L Ambery
1 reference
Kevin Smart
1 reference
Barbara A McQuade
1 reference
17 May 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference